ISRG Stock Chart & Stats
$5903.00
$81.00(1.39%)
―
--
Day’s Range― - ―
52-Week Range$5,770.00 - $11,356.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)219.00
Market Cap
$2.11T
Enterprise Value$136.97K
Total Cash (Recent Filing)$5.22B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)37.5
Beta-0.20
Next Earnings
Oct 20, 2026EPS Estimate
46.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.85
Shares Outstanding353,278,050
10 Day Avg. Volume172
30 Day Avg. Volume219
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)11.34
Price to Sales (P/S)20.08
P/FCF Ratio81.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8,625.41Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering22
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage and steadily growing equity give Intuitive durable financial flexibility. Strong cash and negligible debt support R&D, service infrastructure, buybacks and withstand cyclical capital constraints, reducing refinancing risk and enabling long-term investment in products and training.
High Recurring Revenue MixA dominant recurring revenue base (instruments, accessories, service) creates predictable cash flows and high margins. This razor‑and‑blades model links growth to procedure volume and installed base, supporting durable free cash flow generation and operating leverage even if system placements fluctuate.
Expanding Installed Base & Procedure GrowthA growing installed base and double‑digit procedure growth sustain long-term consumable and service demand. More systems increase lock‑in, training benefits, network effects and cross‑selling of new product variants, underpinning recurring revenue and margin sustainability over multiple years.
Bears Say
China Market PressureWeaker tendering, domestic competition and regulatory clearance delays in China threaten a major growth market. Persistent pricing pressure and slow product approvals can materially reduce international placements and limit upside from a region that historically drove outsized incremental unit growth.
Extended-use Instruments RiskIf extended‑use instruments materially lower per‑procedure instrument spend, Intuitive's core razor‑and‑blades economics could deteriorate. Unquantified rollout and adoption timing add structural revenue and cash‑flow uncertainty, complicating medium‑term instrument and accessory revenue forecasts.
Procedure-mix Headwinds From GLP-1 AdoptionBroader adoption of GLP‑1 therapies can structurally reduce demand for certain higher‑margin surgical procedures, shifting case mix to lower‑revenue ops. Sustained changes in clinical pathways would compress instrument consumption per patient and pressure recurring revenue and average revenue per procedure.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $5770.00 and its highest was $11356.00 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $2.11T.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Oct 20, 2026 which is in 87 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Jul 16, 2026. The company reported $49.025 earnings per share for the quarter, beating the consensus estimate of $43.965 by $5.06.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 46.17.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 353,278,050 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $49.025 in its last earnings report, beating expectations of $43.965. Following the earnings report the stock price went down -12.245%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in MX:ISRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8,625.41 (― Downside)
$8,625.41 (― Downside)
Blogger Sentiment
Bullish
MX:ISRG Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 86%
Bearish news 14%
Bearish news 14%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.54%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
ISRG Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$8,625.41